Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | GPR4 | P46093 | 7/20 | 0.35 |
| ▸ | CTSK | P43235 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30299348 | 0.92 | GPR4 (0.42) | LTA4HLMNAGPR4CTSKKMT2A | |
| SCHEMBL30299358 | 0.91 | GPR4 (0.43) | LTA4HGPR4CTSKKMT2A | |
| SCHEMBL30299399 | 0.89 | GPR4 (0.37) | LMNAGPR4CTSKKMT2AKDM4E | |
| SCHEMBL30299400 | 0.86 | LTA4H (0.47) | SMN1; SMN2LTA4HLMNAGAACHRM3 | |
| SCHEMBL30299272 | 0.85 | LTA4H (0.46) | SMN1; SMN2LTA4HLMNAGAACHRM3 | |
| SCHEMBL30299269 | 0.84 | MEN1 (0.45) | KMT2AKDM4EMEN1 | |
| SCHEMBL30299386 | 0.83 | SIGMAR1 (0.40) | SMN1; SMN2LTA4HLMNAGAACHRM3 | |
| SCHEMBL30299395 | 0.81 | TSHR (0.38) | SMN1; SMN2LTA4HLMNAGAACHRM3 | |
| SCHEMBL30299376 | 0.81 | GPR4 (0.38) | LTA4HGPR4CTSK | |
| SCHEMBL30299394 | 0.81 | GPR4 (0.43) | SMN1; SMN2PKMHTTLMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115916344-A | AXL inhibitors for antiviral therapy | 卑尔根生物股份公司 | 2023-04-04 | — | — | CN | disclosed |